From PolyU Research to Geneva Global Debut: GOOD Vision oka³y! ™ Redefines Precision in Freeform Orthokeratologyby Asia Today Team March 9, 2026 0 GENEVA, SWITZERLAND – Media OutReach Newswire – 9 March 2026 – GOOD Imaginative and prescient Applied sciences Co., Restricted, a ...
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissionsby Asia Today Team December 21, 2025 0 MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 /PRNewswire/ — Telix Prescribed drugs Restricted (ASX: TLX, NASDAQ: TLX, “Telix”) at present ...